Two members of the NAIFA Lifetime Healthcare Center Legislative Working Group, Steve Cain (NAIFA-California) and Steve Schoonveld (NAIFA-Massachusetts), participated in a general session panel at the NCOIL Summer Meeting on trends and innovations in the long-term care insurance marketplace. They were joined by representatives from the American Council of Life Insurers (ACLI) and WA Cares for a dynamic discussion before insurance legislators and regulators from all over the country. The panel emphasized the urgency of planning ahead and highlighted the need for both public and private solutions. Programs like WA Cares offer a foundation, but private LTC insurance remains vital for greater choice and flexibility. With 70% of Americans likely to need LTC, early education, planning, and policy innovation are essential to reduce the financial and emotional burden on families and ensure aging with dignity.
Other highlights from the NCOIL 2025 Summer Meeting include:
- The Life Insurance & Financial Planning Committee meeting, chaired by Rep. Brenda Carter (MI) and Vice-Chaired by Sen. Pam Helming (NY), members discussed a proposed NCOIL model act concerning life insurers’ use of genetic information. Rep. Carter introduced the model, followed by presentations from Alex Meixner (ALS Association) and Jan Graeber (ACLI). Graeber stated the model balanced consumer protection and insurer needs, emphasizing that insurers should have access to the same genetic information as applicants to ensure fair pricing. Legislators raised concerns about discrimination, outdated underwriting practices, and how genetic markers differ from diagnosed illnesses. While Graeber clarified that underwriting considers multiple factors, including lifestyle, and that re-underwriting is possible without premium increases, some members expressed concerns about fairness, affordability, and risk pooling. The committee agreed that the conversation was important and would continue at the next NCOIL meeting.
- During the Financial Services & Multi-Lines Issues Committee, chaired by Asm. Jarett Gandolfo (NY) and Vice-Chaired by Sen. Tim Grayson (CA), members held an initial discussion on a proposed NCOIL model act addressing insurers' use of artificial intelligence (AI). Bill sponsors Asm. Erik Dilan (NY) and Rep. Forrest Bennett (OK) emphasized the need for human oversight in insurance decisions, especially claim denials, while acknowledging the draft was meant to spark conversation. Presenters from industry groups including ACLI, NAMIC, APCIA, AHIP, and others highlighted the benefits of AI—such as efficiency and error reduction—while cautioning against overregulation that could hinder innovation. Some advocated for relying on existing laws and NAIC guidance already adopted in many states. Legislators expressed interest in striking a balance between innovation and consumer protection, with several noting concerns about transparency, fairness, and the broader implications of AI in underwriting and claims. One specific concern pertained to the use of AI in underwriting and claims. No vote was taken, and discussion is expected to continue at future meetings.
- In the Financial Services & Multi-Lines Issues Committee, members continued their discussion on the proposed NCOIL Prior Authorization Reform Model Act. While no vote was planned, the committee reviewed various stakeholder comments and suggested amendments from groups such as the AMA, Arthritis Foundation, and Blue Cross Blue Shield Association. Presenters emphasized the need for reform to ensure timely access to medically necessary care, especially for patients with complex conditions, while still allowing prior authorization as a cost-containment tool. Industry representatives acknowledged recent efforts to streamline processes, such as dropping prior authorization requirements for certain procedures and promoting electronic systems. Legislators raised concerns around definitions of “urgent” care, retroactive denials, and the qualifications of those making care decisions. Discussions also touched on gold carding programs and the balance between innovation, transparency, and patient protections. The committee anticipates continuing work on the model during an interim meeting.